Clinical management and outcomes of snake envenomation: a case series
Volume_6,Issue_2
PDF

Keywords

Envenomation
Antivenoms
Snake venom
Clinical care
Snakebite Management

How to Cite

George, J. S., Selvaraj , H., Munir , A. and Kumar, A. (2025) “Clinical management and outcomes of snake envenomation: a case series: Snake Envenomation: A Case Series”, One Health & Risk Management , 6(2), pp. 67-76. doi: 10.38045/ohrm.2025.2.06.

Abstract

Introduction. In tropical rural communities, snakebite envenomation is among the main causes of morbidity and mortality. It results in shock, hemorrhage, tissue necrosis, and swelling. Diagnosing and identifying snake species is challenging, necessitating thorough clinical assessments and point-of-care tests. Hence this case series examines follow up on the course of clinical care and management of snake envenomation cases in Erode District, India, a location known for poisonous snakes such as the spectacled cobra (Naja naja), Russell’s viper (Daboia russelii), and common krait (Bungarus caeruleus).

Materials and methods. This case series summarizes the hospital experience of patients with snake envenomation who were hospitalized to a local government medical college and hospital.

Rezults. Five patients were confirmed or suspected of having been envenomated by a snake. Four patients received antivenom. The regional venom response team offered management guidance and antivenom. One patient’s hospitalization was protracted and worsened by respiratory failure and corneal dystrophies. All patients survived and were discharged.

Conclusions. This series emphasizes the necessity of early and comprehensive management measures to reduce morbidity and mortality from snake envenomation, as well as the need for ongoing research and interventions to improve patient care in a variety of clinical settings.

https://doi.org/10.38045/ohrm.2025.2.06
PDF

|Views: 0| |PDF Downloads: 0|


PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Jeeven Susan George, Hemalatha Selvaraj , Afreen Munir , Arbind Kumar

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370